grant

Predicting disease progression in patients with myeloid neoplasms to enable early intervention

Also known as: Ideas Grants

Funded by National Health and Medical Research Council
Managed by University of South Australia
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/2021560]

Funding Amount $1,283,269.20

Full description Myelodysplastic and myeloproliferative neoplasms (MDS/MPN) are blood cancers with multiple genetic mistakes that have a risk of progressing to acute myeloid leukaemia (AML), a rapid and fatal disease. There are no reliable approaches to predict who is going to develop AML. Based on the idea that a skewed hormone receptor is the cause of the problem we propose to identify its genetic fingerprint that can predict when MDS and MPN will transform to AML to enable faster and better treatments.

Chief Investigator Prof Angel Lopez

Date Announced 2022-12-14T00:00:00

Sector University

Click to explore relationships graph
Help

Related Organisations

Spatial Coverage And Location

text: SA

Subjects
Biochemistry and Cell Biology | Biological Sciences | Basic Science Research | Signal Transduction | cytokine receptor | haematological malignancy | risk prediction | stem cell biology | transformation |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA